Mustapha Bakali
President bij Clinton Health Access Initiative
Profiel
Mustapha Leavenworth Bakali founded LeapFrog Investment LLP, where he worked as Chairman & Managing Partner from 2010 to 2012.
Mr. Bakali also currently works at Phoqus Pharmaceuticals (UK) Ltd., as Director, George Clinical Pty Ltd., as Director, George Medicines UK Ltd., as Director, and Clinton Health Access Initiative, as President & Chief Operating Officer from 2012.
Mr. Bakali also formerly worked at Genocea Biosciences, Inc., as President & Chief Executive Officer from 2011 to 2013, reMYND NV, as Chairman, ImevaX GmbH, as Chairman, Seqirus Vaccines Ltd., as Director-Worldwide Sales & Marketing, Phoqus Pharmaceuticals Plc, as Non-Executive Director, ID Biomedical Corp., as Chief Operating Officer from 2004 to 2006, Intercell AG, as Member-Management Board & Chief Business Officer in 2012, Napo Pharmaceuticals, Inc., as Member-Supervisory Board, Powderject Pharmaceuticals Plc, as Chief Operating Officer from 2001 to 2004, and Osisko Mining Corp., as Member-Supervisory Board from 2012 to 2013.
Mr. Bakali received his graduate degree from the University of London.
Actieve functies van Mustapha Bakali
Bedrijven | Functie | Begin |
---|---|---|
Phoqus Pharmaceuticals (UK) Ltd.
Phoqus Pharmaceuticals (UK) Ltd. Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals (UK) Ltd. manufactures pharmaceuticals products. The firm develops advanced drug delivery systems. It conducts research & development on natural sciences and engineering. The company was founded on December 29, 1997 and is located in London, UK. | Director/Board Member | 21-08-2009 |
Clinton Health Access Initiative
Clinton Health Access Initiative Miscellaneous Commercial ServicesCommercial Services The Clinton Health Access Initiative (CHAI) is a health organization that is dedicated to saving lives, reducing the burden of disease, and strengthening health systems. CHAI is based in Boston, MA, and the CEO of the non-profit company is Deepak Verma. The organization's focus is on improving healthcare in developing countries. | President | 01-05-2012 |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | Director/Board Member | - |
George Clinical Pty Ltd.
George Clinical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services George Clinical Pty Ltd. provides clinical research services. It offers robust operational expertise and scientific leadership in vascular, renal and respiratory diseases, neurology and endocrinology. The company was founded by Stephen MacMahon in 2008 and is headquartered in Newtown, Australia. | Director/Board Member | - |
Eerdere bekende functies van Mustapha Bakali
Bedrijven | Functie | Einde |
---|---|---|
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Director/Board Member | 01-05-2012 |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Chief Operating Officer | 01-04-2006 |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Chief Operating Officer | 01-02-2004 |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Chairman | - |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Chairman | - |
Opleiding van Mustapha Bakali
University of London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GENOCEA BIOSCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 14 |
---|---|
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Health Technology |
Phoqus Pharmaceuticals Plc
Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Health Technology |
Powderject Pharmaceuticals Plc
Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Health Technology |
Osisko Mining Corp.
Osisko Mining Corp. Precious MetalsNon-Energy Minerals Osisko Mining Corp. is a mining company, which is focused on acquiring, exploring, developing and mining gold properties. The company holds interest in the Canadian Malartic gold mine located in the Abitibi mining district; owns the advanced stage Hammond Reef project in Northern Ontario; and is also pursuing exploration on a number of properties, including the Upper Beaver project in Northeastern Ontario. Osisko Mining was founded by John Feliks Burzynski, Sean E. O. Roosen and Robert P. Wares on February 18, 1982 and is headquartered in Montreal, Canada. | Non-Energy Minerals |
Phoqus Pharmaceuticals (UK) Ltd.
Phoqus Pharmaceuticals (UK) Ltd. Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals (UK) Ltd. manufactures pharmaceuticals products. The firm develops advanced drug delivery systems. It conducts research & development on natural sciences and engineering. The company was founded on December 29, 1997 and is located in London, UK. | Health Technology |
LeapFrog Investment LLP | |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
Clinton Health Access Initiative
Clinton Health Access Initiative Miscellaneous Commercial ServicesCommercial Services The Clinton Health Access Initiative (CHAI) is a health organization that is dedicated to saving lives, reducing the burden of disease, and strengthening health systems. CHAI is based in Boston, MA, and the CEO of the non-profit company is Deepak Verma. The organization's focus is on improving healthcare in developing countries. | Commercial Services |
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
George Medicines UK Ltd.
George Medicines UK Ltd. BiotechnologyHealth Technology George Medicines UK Ltd. is a company focused on late stage drug development to improve the management of non-communicable diseases. The company is based in London, UK. The British company does this by creating single-pill, multi-mechanism combinations of existing medicines. Stefan König has been the CEO of the company since 2021. | Health Technology |
George Clinical Pty Ltd.
George Clinical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services George Clinical Pty Ltd. provides clinical research services. It offers robust operational expertise and scientific leadership in vascular, renal and respiratory diseases, neurology and endocrinology. The company was founded by Stephen MacMahon in 2008 and is headquartered in Newtown, Australia. | Commercial Services |